AZTA News and Press, Azenta Inc. From 03/15/23

Azenta to Participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum Azenta to Participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum PR Newswire BURLINGTON, Mass. , March 15, 2023 /PRN...

Azenta Publishes its Environmental, Social, & Governance (ESG) Report Azenta Publishes its Environmental, Social, & Governance (ESG) Report PR Newswire BURLINGTON, Mass. , March 7, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the p...

Azenta to Participate in Upcoming Investor Conferences PR Newswire BURLINGTON, Mass. , Feb. 28, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in two upcoming investor conferences: Cowen 43rd Annual...

Azenta Launches Cryo Store Pico™, a Novel Automated Cryogenic Storage System Designed for Clinical and Laboratory Applications PR Newswire An Extension of Azenta's Innovative and Market Leading Automated Cryogenic Technology BURLINGTON, Mass. , Feb. 27...

Ansa Biotechnologies has announced the appointment of Matthew F. McManus, M.D, Ph.D., as Independent Director and Chairperson of the company’s Board of Directors. Dr. McManus brings decades of experience in the life sciences industry to the Board. He was most recently EVP ...

Azenta, Inc. (AZTA) Q1 2023 Earnings Conference Call February 08, 2023, 04:30 PM ET Company Participants Sara Silverman - Head, IR Stephen Schwartz - CEO, President & Director Lindon Robertson - EVP & CFO Conference Call Participants Jacob Johnson -...

The following slide deck was published by Azenta, Inc. in conjunction with their 2023 Q1 earnings call. For further details see: Azenta, Inc. 2023 Q1 - Results - Earnings Call Presentation

Azenta to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Azenta to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference PR Newswire BURLINGTON, Mass. , Feb. 10, 2023 /...

Azenta ( NASDAQ: AZTA ) is trading 15% lower after the company forecast second revenue and non-GAAP EPS below analysts estimate. The company sees Q3 revenue between $156M to $171M, below analysts estimate of $173.71M. Non-GAAP diluted earnings per share is expected to be ...

Azenta press release ( NASDAQ: AZTA ): Q1 Non-GAAP EPS of $0.12. Revenue of $178M (+27.1% Y/Y). Delivered Organic Growth Excluding COVID of 7% Reducing Cost Structure to Deliver Two Points of Margin Enhancement in 2 nd Half FY23 Guidance for Second Quarter Fisc...